论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
库奇尤单抗治疗斑块型银屑病出现白塞氏病样药物反应
Authors Wei Y, Zhang P, Chuan J, Ye J, Liu T
Received 16 September 2025
Accepted for publication 18 December 2025
Published 8 January 2026 Volume 2026:19 567115
DOI https://doi.org/10.2147/CCID.S567115
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Prof. Dr. Rungsima Wanitphakdeedecha
Yanjie Wei,1,* Peilian Zhang,2,* Jintao Chuan,1 Jianzhou Ye,2 Tao Liu3
1Department of Dermatology, The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine, Kunming, People’s Republic of China; 2Department of Dermatology, Yunnan Provincial Hospital of Traditional Chinese Medicine, Kunming, Yunnan, People’s Republic of China; 3Department of Pathology, Yunnan Provincial Hospital of Traditional Chinese Medicine, Kunming, Yunnan, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Peilian Zhang, Department of Dermatology, Yunnan Provincial Hospital of Traditional Chinese Medicine, Kunming, People’s Republic of China, Email mzczpl1968@163.com
摘要:
目的:本报告旨在介绍一例罕见的反常反应表现为白塞氏病样的特征,在接受司库奇尤单抗治疗银屑病 3 个月后出现的不良反应。
患者与方法:一名38岁女性患者,有近30年的银屑病病史。该患者在接受七剂司库奇尤单抗治疗后(总剂量为2100mg),银屑病病情明显改善。然而,她出现了咽喉疼痛、扁桃体及外生殖器疼痛性溃疡,躯干、四肢毛囊炎样丘疹以及双下肢伸侧结节性红斑皮损等不良反应。实验室检查未发现感染证据,皮肤活检的组织病理学示浅层和深层血管周围及间质炎症,伴有大量淋巴细胞、中性粒细胞和嗜酸性粒细胞浸润,该患者被诊断为司库奇尤单抗诱发的类似白塞氏病。立即停用司库奇尤单抗,给予沙利度胺 50mg 每日三次;秋水仙碱 50mg每日两次治疗。
结果:治疗两周后,口腔及外生殖器溃疡消退,躯干、四肢毛囊炎样丘疹、结节性红斑好转,仅留下色素沉着。后改用乌司奴单抗标准剂量规律治疗,银屑病控制佳,随访4年,未见白塞病样皮疹复发。
结论:我们的报告旨在提醒医生在临床诊断和治疗过程中,必须对患者进行密切随访,以发现抗IL17治疗中可能出现的这种不常见但重要的矛盾反应。此外,明确不良反应的发生时间至关重要,这有助于临床医生及时采取预防措施,降低风险,并迅速识别不良反应。